114 related articles for article (PubMed ID: 6705284)
1. A dose response study with oral prenalterol in patients with chronic congestive cardiac failure.
Hendry WG; Comerford MB; Besterman EM
Clin Cardiol; 1984 Jan; 7(1):23-8. PubMed ID: 6705284
[TBL] [Abstract][Full Text] [Related]
2. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.
Currie PJ; Kelly MJ; Middlebrook K; Federman J; Sainsbury E; Ashley J; Pitt A
Br Heart J; 1984 May; 51(5):530-8. PubMed ID: 6326784
[TBL] [Abstract][Full Text] [Related]
3. Effects of prenalterol administered orally in patients with congestive heart failure.
Hjalmarson A; Abelardo N; Caidahl K; Reyes C; Waagstein F; Wallentin I; Wikstrand J; Estrada-Yamamoto M
Acta Med Scand Suppl; 1982; 659():201-20. PubMed ID: 6127890
[TBL] [Abstract][Full Text] [Related]
4. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.
Glover DR; Wathen CG; Murray RG; Petch MC; Muir AL; Littler WA
Br Heart J; 1985 Feb; 53(2):208-15. PubMed ID: 2857088
[TBL] [Abstract][Full Text] [Related]
5. The hemodynamic actions of prenalterol in left ventricular failure.
Awan NA; Evenson MK; Needham KE; Mason DT
Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.
Roubin GS; Choong CY; Devenish-Meares S; Sadick NN; Fletcher PJ; Kelly DT; Harris PJ
Circulation; 1984 May; 69(5):955-62. PubMed ID: 6142775
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
Tweddel AC; Murray RG; Pearson D; Martin W; Hutton I
Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
[TBL] [Abstract][Full Text] [Related]
9. Prenalterol, an oral beta-1 adrenoceptor agonist, in the treatment of chronic heart failure.
Sharpe DN; Coxon R
Eur J Clin Pharmacol; 1983; 25(4):539-45. PubMed ID: 6653650
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
Klein W; Brandt D; Maurer E
Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
[TBL] [Abstract][Full Text] [Related]
11. Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balance.
Wahr DW; Swedberg K; Rabbino M; Hoyle MJ; Curran D; Parmley WW; Chatterjee K
Am J Med; 1984 Jun; 76(6):999-1005. PubMed ID: 6731471
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent haemodynamic response to prenalterol in patients with congestive heart failure.
Leinberger H; Mäurer W; Haueisen H; Schuler G; Kübler W
Acta Med Scand Suppl; 1982; 659():299-306. PubMed ID: 6127896
[TBL] [Abstract][Full Text] [Related]
14. Contractile, coronary, and metabolic effects of the acute and long-term treatment of cardiac failure with prenalterol.
Strauer BE; Bohn I; Hahn B; Kment A; Motz U
J Cardiovasc Pharmacol; 1984; 6(3):491-8. PubMed ID: 6202977
[TBL] [Abstract][Full Text] [Related]
15. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
[TBL] [Abstract][Full Text] [Related]
16. Acute haemodynamic effects of oral prenalterol in severe heart failure.
Petch MC; Wisbey C; Ormerod O; Scott C; Goodfellow RM
Br Heart J; 1984 Jul; 52(1):49-52. PubMed ID: 6146324
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of intravenous prenalterol in patients on long-term digoxin therapy for congestive heart failure.
Dahlström U; Karlsson E; Wranne B
Eur Heart J; 1982 Aug; 3(4):331-8. PubMed ID: 7128622
[No Abstract] [Full Text] [Related]
18. [Chronic therapy of congestive cardiomyopathy: effects of prenalterol and digoxin].
Schwarz KR; Hofmann M; Mäurer W; Kadel C; von Olshausen K; Rauch B; Kübler W
Z Kardiol; 1985 Jul; 74(7):374-83. PubMed ID: 3929486
[TBL] [Abstract][Full Text] [Related]
19. Prenalterol as long-term therapy for chronic congestive heart failure. A randomized cross-over trial.
Dahlström U; Areskog M; Wranne B; Karlsson E
Acta Med Scand; 1984; 216(2):199-207. PubMed ID: 6149671
[TBL] [Abstract][Full Text] [Related]
20. Cardioselectivity of prenalterol and isoproterenol.
Jennings G; Bobik A; Oddie C; Hargreaves M; Korner P
Clin Pharmacol Ther; 1983 Dec; 34(6):749-57. PubMed ID: 6641090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]